LYB // LyondellBasell Industries NV Ordinary Shares Class A (Netherlands)
FA <GO> NYSE CIK 0001489393 ↗ Materials • Major Chemicals
$65.37 ▼ -1.76
(-2.62%)
MKT CAP: $21.12B • VOL: 3.81M
52W L $42 52W H $84
LYB // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $30.15B | $33.39B | $33.34B |
| YoY Revenue Growth % | -9.7% | +0.2% | — |
| Gross Profit | $2.58B | $4.64B | $14.67B |
| Gross Margin % | 8.5% | 13.9% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$420.0M | $1.92B | $2.73B |
| Operating Margin % | -1.4% | 5.7% | 8.2% |
| Net Income (GAAP) | -$738.0M | $1.37B | $2.12B |
| EBITDA (Normalized) | $1.08B | $3.39B | $3.93B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.26B | $3.82B | $4.94B |
| Capital Expenditures (CapEx) | $1.88B | $1.84B | $1.50B |
| Free Cash Flow (FCF) | $384.0M | $1.98B | $3.44B |
| FCF Margin % | 1.3% | 5.9% | 10.3% |
| Return on Invested Capital (ROIC %) | -2.3% | 8.7% | 8.9% |
| Cash & Short-Term Equivalents | $3.44B | $3.38B | $4.40B |
| Total Debt (Short + Long Term) | $7.96B | $8.36B | $9.36B |
| Total Stockholders' Equity | $10.08B | $12.46B | $19.20B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LYB.